Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CBD Life Sciences Inc. (CBDL)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00030.0000 (0.00%)
At close: 03:56PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/30/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 3.35
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.0198
52 Week Low 30.0002
50-Day Moving Average 30.0003
200-Day Moving Average 30.0011

Share Statistics

Avg Vol (3 month) 3391.25M
Avg Vol (10 day) 3270.77M
Shares Outstanding 53.58k
Implied Shares Outstanding 6N/A
Float 81.2B
% Held by Insiders 10.00%
% Held by Institutions 10.36%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 04, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Feb 04, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)1.43%

Management Effectiveness

Return on Assets (ttm)0.25%
Return on Equity (ttm)-388.65%

Income Statement

Revenue (ttm)225.67k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)937.70%
Gross Profit (ttm)36.63k
EBITDA N/A
Net Income Avi to Common (ttm)-1.76M
Diluted EPS (ttm)-0.0020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.95k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.43
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-876.8k
Levered Free Cash Flow (ttm)-39.36k
Advertisement
Advertisement